IncFact
Company Profiles: Revenue, Growth, Competition

NEW HEALTH SCIENCES Revenue, Growth & Competitor Profile

DBA HEMANEXT
Last updated:

Company Awards

VC / Private Equity
Venture Capital / Private Equity
Fast Growing
Fastest Growing
Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for New Health Sciences

Access the complete profile.

New Health Sciences Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry339112 Surgical & Medical Instrument Manufacturing
Additional NAICS Codes33911
5417 Scientific Research & Development Services
541712
541715
Address6903 Rockledge Dr Ste 230
Bethesda, MD 20817

Note: Revenues for privately held companies are statistical evaluations.


New Health Sciences's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Surgical & Medical Instrument Manufacturing industry.


New Health Sciences's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

New Health Sciences Annual Revenue and Growth Rate

New Health Sciences Revenue Est.
($ Million)
Growth Rate (%)# Employees
2018 Details in Premium Report
2017
2016
2015
2014
2013
2012


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: New Health Sciences's revenues are gauged from an analysis of company filings.



Investor Activity

New Health Sciences has actively raised capital from investors. These investors may include private investors, venture capital firms, or other investment vehicles.

Date Investors Percent Raised Target Size
October 25, 2019 7 31%$15 MM
Complete list of funding rounds and total amounts in the Company Report




New Health Sciences's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
New Health Sciences Revenue (Sales) New Health Sciences Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that New Health Sciences is developing and marketing. New Health Sciences's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
HEMANEXT ONE
Blood collection kit comprised of blood collection bags, tubing for medical purposes, and a phlebotomy needle; Blood collection kit comprised of blood collection bags and tubing for medical purposes; Blood containers for medical purposes, sold empty
01/24/2019
HEMANEXT
Blood collection kit comprised of blood collection bags, tubing for medical purposes, and a phlebotomy needle; Blood collection kit comprised of blood collection bags and tubing for medical purposes; Blood containers for medical purposes, sold empty
09/27/2017
DYNAMIC VASCULAR ANALYSIS
Providing data interpretation services, namely, providing information, advice and data on medical imaging related to vascular disease; Medical services, namely, offering classification of vascular diseases according to the vascular physiological signature; providing medical information and data via a global computer network; Medical services, namely, medical analysis and consultation based on the measuring and describing of changes in vascular function, which characterize the presence or risk of damage and disease
01/04/2006

See all trademarks and details in the Full Report.


Recession Risk

Determine whether New Health Sciences grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof New Health Sciences is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



Market Share of New Health Sciences's Largest Competitors

A competitive analysis shows these companies are in the same general field as New Health Sciences, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
HANDICARE USAMaryland Heights, MO100 
GAUMARD SCIENTIFICMiami, FL69 
SHL PHARMADeerfield Beach, FL29 
MD24Surprise, AZ14 
BIODERMLargo, FL11 
ALLIANCE PARTNERSSan Antonio, TX8 
MAGNOLIA MEDICAL TECHNOLOGIESSeattle, WA7 
SKY MEDICALSunrise, FL4 
LIFE INSTRUMENTBraintree, MA3 




Nearby Competitors

These companies are similar in business line and location to New Health Sciences. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
NEW HEALTH SCIENCESBethesda, MD100 
AGNOVOS HEALTHCARERockville, MD93 
ORTHOCARE SOLUTIONSNorth Bethesda, MD55 
LAWSON MEDICAL SUPPLIESGaithersburg, MD47 
ZALGEN LABSGermantown, MD30 
NUO THERAPEUTICSGaithersburg, MD27 




Future Competition: New Health Sciences's Fastest Growing Competitors

These companies are in the same general field as New Health Sciences and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
New Health Sciences Competitors